Overview
Chai Discovery, a San Francisco-based AI company, has raised $130 million in a Series B financing round co-led by Oak HC/FT and General Catalyst, achieving a valuation of $1.3 billion. The funding aims to advance AI-driven molecular design, addressing the challenge of predicting and reprogramming biochemical molecule interactions.
Products
Loading...
Recent Deals
Investors: Oak HC/FT, General Catalyst
Chai Discovery, a San Francisco-based AI company, has raised $130 million in a Series B financing round co-led by Oak HC/FT and General Catalyst, achieving a valuation of $1.3 billion. The funding aims to advance AI-driven molecular design, addressing the challenge of predicting and reprogramming biochemical molecule interactions.
Investors: Oak HC/FT, General Catalyst
Chai Discovery, a San Francisco-based biotech, secured $130 million at a $1.3 billion valuation to develop a computer-aided design suite for molecules. Key investors include Oak HC/FT and General Catalyst. The funding aims to enhance drug discovery efficiency, targeting complex diseases.